About Us
Roche Diabetes Care
With more than 40 years of experience in the diabetes care space and with 4,500 employees in more than 100 countries, Roche Diabetes Care continues to focus on everyday support to help people with diabetes find true relief, no matter where they live.
With our Accu-Chek and mySugr brands, we offer one of the most comprehensive portfolios of diabetes management products and services to make it easier for people with diabetes and those who care for them to connect what counts.
Globally, Accu-Chek is a leading provider of blood sugar monitoring systems and insulin pumps. With more than 40 years experience, our number one goal is to help people living with diabetes track and manage their blood sugar so they may have better control of their health.
Serving 30 million people with diabetes worldwide every day, the Accu-Chek brand unites a variety of modern and connected diabetes management solutions to provide people living with diabetes with deeper knowledge for ever-better outcomes.
Part of Roche Diabetes Care, mySugr is an easy-to-use digital health app that simplifies life for people with diabetes. Accu-Chek blood glucose meters seamlessly connect to the mySugr app, automatically transferring blood sugar readings directly into the app.
Roche Diabetes Care is part of the Roche Group. Throughout our 125-year history, Roche has grown into one of the world’s largest biotech companies, as well as a leading provider of in-vitro diagnostics and a global supplier of transformative innovative solutions across major disease areas.
Our commitment to our people, partners, stakeholders and, most importantly, our patients remains as strong as it was on the first day of our journey.